This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Allergan’s VISTABEL® (botulinum toxin type a) receives positive opinion from ansm for treatment of moderate to severe forehead lines in adult patients in 30 european countries
Allergan plc, a global biopharmaceutical company, announced that VISTABEL® has received a Positive Opinion from the Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) for the